Mgp Ingredients (MGPI) Cash & Equivalents (2010 - 2026)

Mgp Ingredients (MGPI) has reported Cash & Equivalents for 16 consecutive years, with $17.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Equivalents rose 2.74% year-over-year to $17.8 million; the TTM figure through Jun 2026 stood at $17.8 million (up 2.74% YoY), while the FY2025 annual figure was $18.5 million, down 26.96% from the prior year.
• Cash & Equivalents improved to $17.8 million in Q2 2026 per MGPI's latest filing, from $10.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $50.7 million in Q3 2022 and bottomed at $10.4 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $24.9 million across 5 years, with a median of $20.9 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 213.54% — and 2023, when it slumped 61.6%.
• Mgp Ingredients' Cash & Equivalents stood at $47.9 million in 2022, then plunged by 61.6% to $18.4 million in 2023, then jumped by 37.44% to $25.3 million in 2024, then fell by 26.96% to $18.5 million in 2025, then decreased by 3.61% to $17.8 million in 2026.
• Business Quant data shows MGPI's Cash & Equivalents at $17.8 million in Q2 2026, $10.4 million in Q1 2026, and $18.5 million in Q4 2025.